Symbol Insights

You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.

Insights for Bio-N-Tech
NASDAQ: BNTX
06 - Growing & Well-Funded but Loss-Making
Sector: Health & Fitness
Industry: Medicine - Production & Distribution
Today's Price
updated on: 		117.61 (-1.94%)
Open 119.47 (-1.56%)
High (Upside %) 120.18 (2.19%)
Low (Downside %) 117.49 (0.1%)
P. Close 119.94 (-1.94%)
Open-High % 0.59%
Open-Low % 1.66%
Low-High % 2.29%
Active Buy Quantity 0
Active Sell Quantity 0
% Overtraded
Current Mood bearish
Previous Data
data from:
Open-High % 0.59%
Open-Low % 1.66%
Low-High % 2.29%
Open-Close % -1.56%
Low-Close % 0.1%
High-Close % 2.14%

BNTX is a Stock listed in the US on the NASDAQ under the ticker 'BNTX'

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A, as well as strategic partnership the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen africa's mrna vaccine ecosystem. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

source:https://finance.yahoo.com/BNTX/profile

Predicted Prices
Key Low (open) Low (high) Close-Down (open) Close-Down (high) Close-Up (open) Close-Up (low) High (open) High (low)
Low Volatility 118.52
45.63% hit 		117.86
56.61% hit 		119.08
19.49% hit 		119.16
45.93% hit 		121.61
18.82% hit 		117.89
47.95% hit 		119.8
46.68% hit 		119.8
56.61% hit
Average Volatility 116.71
30.99% hit 		115.22
33.68% hit 		117.34
14.94% hit 		117.32
33.53% hit 		123.41
15.24% hit 		120.05
33.38% hit 		122.19
30.92% hit 		122.54
33.68% hit
High Volatility 112.18
3.36% hit 		109.59
3.06% hit 		113.85
3.51% hit 		112.03
3.29% hit 		126.98
3.36% hit 		125.39
3.96% hit 		128.22
3.58% hit 		128.84
3.06% hit

BNTX's predicted prices using open from of 119.47 and data until date . Current Price is 117.61

Basic Stats
Market Cap-Display Market Cap-Actual Market Cap Enterprise Value-Display Enterprise Value-Actual Enterprise Value Trailing P/E Forward P/E Price/Sales Price/Book Enterprise Value/Revenue Enterprise Value/EBITDA Profit Margin Operating Margin Return on Assets Return on Equity Revenue-Display Revenue-Actual Revenue Quarterly Revenue Growth EBITDA-Display EBITDA-Actual EBITDA Diluted EPS Quarterly Earnings Growth Total Cash-Display Total Cash-Actual Total Cash Total Debt-Display Total Debt-Actual Total Debt Total Debt/Equity Current Ratio Operating Cash Flow-Display Operating Cash Flow-Actual Operating Cash Flow Levered Free Cash Flow-Display Levered Free Cash Flow-Actual Levered Free Cash Flow % Held by Insiders % Held by Institutions
29.67 B 29670000000.0 29.67 12.55 B 12550000000.0 12.55 166.87 7.04 9.42 1.49 3.97 110.81 -15.36% 1.68% -1.24% -2.40% 3.04 B 3040000000.0 3.04 39.00% -270.0 mn -274500000.0 -0.27 -2.02 23.40% 16.71 B 16710000000.0 16.71 240.0 mn 243700000.0 0.24 0.0127 7.33 1.52 B 1520000000.0 1.52 1.41 B 1410000000.0 1.41 61.65% 20.85%

source:https://finance.yahoo.com/BNTX/key-statistics

Reading Information

source:https://finance.yahoo.com/BNTX/key-statistics

source:https://www.google.com/finance/quote/BNTX:NASDAQ

source:https://finance.yahoo.com/BNTX/analysis

source:https://finance.yahoo.com/BNTX/fair-value

Upside-Downside Spread
Key Weighted 5D 1M 3M 6M 1Y 3Y 10Y
Upside % (high) 15.05% 5.75% (124.37) 9.91% (129.27) 9.91% (129.27) 11.8% (131.49) 11.8% (131.49) 60.76% (189.074) 294.52% (464)
Downside % (low) 12.35% 2.2% (115.02) 5.52% (111.12) 19.81% (94.31) 34.93% (76.5301) 34.93% (76.5301) 34.93% (76.5301) 89.35% (12.525)
Spread % 2.71% 3.55% 4.4% -9.9% -23.13% -23.13% 25.83% 205.17%

BNTX's price used for computing the stats is 117.61 as on date

Cumulative Return Percent
Key Today 5D 1M 3M 6M 1Y 3Y 10Y
Last Price-Trend PrevClose 0.0% -4.98% -2.16% 3.99% 35.59% 22.51% -34.72%
Last Price 117.61 117.61 117.61 117.61 117.61 117.61 117.61 117.61
Trend-Previous Close 117.61 123.77 120.21 113.1 86.74 96 180.15 None

BNTX's symbol cumulative return percent is computed basis data from date

Return Velocity
5D 2W 1M 3M 6M 1Y
5D window
Metric Mean Median Stdev
Overall -2.09% -0.78% 3.07%
Up 1.67% 2.15% 1.65%
Down -3.51% -3.32% 2.29%
5D Opportunity: BUY-APPROACHING
returns: -4.98% (5.8%), p.close: 123.77
entry: 116.59, exit: 119.01, return: 2.07%
Metric Mean Median Stdev
Overall 1.15% 0.53% 4.5%
Up 3.84% 3.1% 3.16%
Down -2.26% -2.43% 2.24%
5D Opportunity: BUY-ACTIVE
returns: -4.98% (4.5%), p.close: 123.77
entry: 118.2, exit: 118.86, return: 0.56%
Metric Mean Median Stdev
Overall 0.93% 1.72% 6.24%
Up 5.06% 4.75% 4.02%
Down -2.88% -1.68% 3.36%
5D Opportunity: BUY-APPROACHING
returns: -4.98% (6.24%), p.close: 123.77
entry: 116.05, exit: 118.18, return: 1.83%
Metric Mean Median Stdev
Overall 0.61% 0.23% 6.27%
Up 3.99% 2.52% 4.52%
Down -3.15% -2.39% 3.02%
5D Opportunity: BUY-APPROACHING
returns: -4.98% (6.17%), p.close: 123.77
entry: 116.13, exit: 116.29, return: 0.14%
Metric Mean Median Stdev
Overall 1.53% 0.51% 7.35%
Up 4.47% 2.45% 6.05%
Down -2.67% -1.56% 3.02%
5D Opportunity: BUY-APPROACHING
returns: -4.98% (5.7%), p.close: 123.77
entry: 116.72, exit: 115.3, return: -1.21%
Metric Mean Median Stdev
Overall 0.65% 0.18% 6.14%
Up 3.42% 1.83% 4.95%
Down -2.62% -1.79% 2.89%
5D Opportunity: BUY-APPROACHING
returns: -4.98% (5.5%), p.close: 123.77
entry: 116.96, exit: 116.39, return: -0.48%
2W window
Metric Mean Median Stdev
Overall 4.16% 6.3% 4.8%
Up 7.14% 8.61% 3.82%
Down -1.99% -1.19% 2.7%
2W Opportunity:
returns: -0.45% (4.69%), p.close: 118.14
entry: 112.6, exit: 119.91, return: 6.49%
Metric Mean Median Stdev
Overall 2.49% 0.47% 5.19%
Up 8.15% 9.81% 4.19%
Down -2.71% -1.35% 3.29%
2W Opportunity:
returns: -0.45% (6.0%), p.close: 118.14
entry: 111.06, exit: 112.56, return: 1.36%
Metric Mean Median Stdev
Overall 1.32% -0.17% 6.61%
Up 5.95% 3.8% 5.47%
Down -4.1% -3.4% 3.38%
2W Opportunity:
returns: -0.45% (7.47%), p.close: 118.14
entry: 109.31, exit: 110.14, return: 0.76%
Metric Mean Median Stdev
Overall 3.05% 0.23% 9.81%
Up 7.44% 3.74% 9.3%
Down -3.7% -2.78% 3.46%
2W Opportunity:
returns: -0.45% (7.17%), p.close: 118.14
entry: 109.67, exit: 106.83, return: -2.6%
Metric Mean Median Stdev
Overall 1.28% -0.08% 8.53%
Up 5.56% 2.92% 7.46%
Down -3.83% -2.79% 3.85%
2W Opportunity:
returns: -0.45% (7.68%), p.close: 118.14
entry: 109.06, exit: 107.97, return: -1.0%
1M window
Metric Mean Median Stdev
Overall 2.54% 3.19% 5.61%
Up 9.37% 10.33% 3.06%
Down -3.79% -2.93% 2.81%
1M Opportunity:
returns: -2.16% (6.6%), p.close: 120.21
entry: 112.27, exit: 117.3, return: 4.48%
Metric Mean Median Stdev
Overall 1.12% 2.72% 7.62%
Up 7.56% 7.18% 5.43%
Down -6.84% -7.54% 4.17%
1M Opportunity:
returns: -2.16% (11.01%), p.close: 120.21
entry: 106.97, exit: 114.31, return: 6.87%
Metric Mean Median Stdev
Overall 6.91% 3.12% 14.06%
Up 12.81% 8.36% 13.24%
Down -5.22% -5.08% 4.22%
1M Opportunity:
returns: -2.16% (9.44%), p.close: 120.21
entry: 108.86, exit: 107.05, return: -1.66%
Metric Mean Median Stdev
Overall 2.29% 0.45% 12.66%
Up 8.96% 5.46% 10.92%
Down -6.11% -5.61% 5.29%
1M Opportunity:
returns: -2.16% (11.4%), p.close: 120.21
entry: 106.5, exit: 105.53, return: -0.91%

BNTX's symbol current price is 117.61 (0.0%) as on . Yesterday's close was 117.61. It's return velocities are computed basis data from date .

Win Percent
Key Weighted 5D 1M 3M 6M 1Y 3Y
Open-High (> 1.0%) 66.04% 60.0% 68.18% 75.76% 68.18% 58.73% 63.23%
Open-Low (> 1.0%) 70.76% 80.0% 68.18% 62.12% 60.61% 56.75% 57.67%
Open-Close-Up (> 0.5%) 29.07% 20.0% 31.82% 37.88% 40.91% 36.51% 40.34%
Open-Close-Down (> 0.5%) 60.55% 80.0% 54.55% 42.42% 35.61% 38.49% 38.36%
Low-Close-Up (> 1.0%) 64.05% 60.0% 63.64% 71.21% 70.45% 64.29% 63.36%
High-Close-Down (> 1.0%) 88.3% 100% 86.36% 80.3% 65.91% 59.52% 62.43%

BNTX's symbol win percent is computed basis data from date

Associated Tags